Acquisition Opportunity IVD Research was acquired by KVP International in December 2025, indicating potential for expanded contract manufacturing capabilities and potential cross-sell of services within a larger diagnostics portfolio.

Strategic Partnerships Past collaboration with VolitionRx Ltd for US manufacturing suggests receptiveness to strategic partnerships and co-development opportunities that could be leveraged to win new contract work.

Regulatory Strength As an FDA registered and ISO 13485 certified CDMO, IVD Research demonstrates a solid regulatory foundation, making it a credible partner for customers requiring compliant manufacturing and accelerated regulatory readiness.

Market Positioning Operating in the medical device and diagnostics space with a mid-size employee base, the company can position itself as a nimble, specialized contract manufacturer for mid-market diagnostics clients seeking agility and scale.

Growth Signals Revenue visibility in the $1M-$10M range and recent expansion activity via acquisition point to growth trajectory, presenting opportunities to upsell capacity, QMS improvements, and enhanced manufacturing services to expanding diagnostics brands.